S&P 500   2,969.48 (-0.03%)
DOW   26,837.99 (+0.08%)
QQQ   191.43 (+0.17%)
AAPL   237.55 (+0.57%)
MSFT   139.93 (+0.18%)
AMZN   1,727.17 (-0.27%)
NVDA   185.74 (-0.13%)
GE   8.69 (-1.36%)
T   37.49 (-0.24%)
PRI   121.25 (-0.36%)
NFLX   283.79 (+0.30%)
BAC   29.00 (+0.31%)
DIS   129.74 (-0.22%)
S&P 500   2,969.48 (-0.03%)
DOW   26,837.99 (+0.08%)
QQQ   191.43 (+0.17%)
AAPL   237.55 (+0.57%)
MSFT   139.93 (+0.18%)
AMZN   1,727.17 (-0.27%)
NVDA   185.74 (-0.13%)
GE   8.69 (-1.36%)
T   37.49 (-0.24%)
PRI   121.25 (-0.36%)
NFLX   283.79 (+0.30%)
BAC   29.00 (+0.31%)
DIS   129.74 (-0.22%)
Log in

United Therapeutics News Headlines (NASDAQ:UTHR)

$81.49
-0.40 (-0.49 %)
(As of 10/14/2019 11:07 AM ET)
Today's Range
$80.77
Now: $81.49
$81.91
50-Day Range
$77.91
MA: $81.64
$86.47
52-Week Range
$74.31
Now: $81.49
$128.94
Volume3,212 shs
Average Volume515,946 shs
Market Capitalization$3.57 billion
P/E Ratio6.08
Dividend YieldN/A
Beta0.95

Headlines

United Therapeutics (NASDAQ UTHR) News Headlines

Source:
DateHeadline
United Therapeutics: In The Doldrums But Plenty Of Reasons To Watch This Stock CloselyUnited Therapeutics: In The Doldrums But Plenty Of Reasons To Watch This Stock Closely
seekingalpha.com - October 10 at 1:59 PM
$333.52 Million in Sales Expected for United Therapeutics Co. (NASDAQ:UTHR) This Quarter$333.52 Million in Sales Expected for United Therapeutics Co. (NASDAQ:UTHR) This Quarter
www.americanbankingnews.com - September 27 at 1:13 AM
Zacks: Analysts Anticipate United Therapeutics Co. (NASDAQ:UTHR) to Post $2.31 EPSZacks: Analysts Anticipate United Therapeutics Co. (NASDAQ:UTHR) to Post $2.31 EPS
www.americanbankingnews.com - September 26 at 12:40 AM
Investors Who Bought United Therapeutics (NASDAQ:UTHR) Shares Five Years Ago Are Now Down 38%Investors Who Bought United Therapeutics (NASDAQ:UTHR) Shares Five Years Ago Are Now Down 38%
finance.yahoo.com - September 18 at 8:48 AM
United Therapeutics advances new pulmonary hypertension treatment to FDA reviewUnited Therapeutics advances new pulmonary hypertension treatment to FDA review
www.bizjournals.com - September 12 at 2:56 PM
United Therapeutics Trevyent NDA for PAH Accepted by FDAUnited Therapeutics' Trevyent NDA for PAH Accepted by FDA
finance.yahoo.com - September 12 at 2:56 PM
FDA accepts United Therapeutics Trevyent application for PAHFDA accepts United Therapeutics' Trevyent application for PAH
seekingalpha.com - September 11 at 10:58 AM
FDA to review United Therapeutics NDA for TrevyentFDA to review United Therapeutics NDA for Trevyent
seekingalpha.com - September 11 at 10:58 AM
United Therapeutics Announces FDA Acceptance Of Trevyent New Drug Application For ReviewUnited Therapeutics Announces FDA Acceptance Of Trevyent New Drug Application For Review
finance.yahoo.com - September 11 at 10:58 AM
Is United Therapeutics Corporations (NASDAQ:UTHR) CEO Paid Enough Relative To Peers?Is United Therapeutics Corporation's (NASDAQ:UTHR) CEO Paid Enough Relative To Peers?
finance.yahoo.com - August 17 at 6:57 AM
Is United Therapeutics Corporation's (NASDAQ:UTHR) CEO Paid Enough Relative To Peers?Is United Therapeutics Corporation's (NASDAQ:UTHR) CEO Paid Enough Relative To Peers?
finance.yahoo.com - August 17 at 6:57 AM
Edited Transcript of UTHR earnings conference call or presentation 31-Jul-19 1:00pm GMTEdited Transcript of UTHR earnings conference call or presentation 31-Jul-19 1:00pm GMT
finance.yahoo.com - August 11 at 5:22 AM
United Therapeutics Corporation To Present At 2019 Wedbush PacGrow Healthcare ConferenceUnited Therapeutics Corporation To Present At 2019 Wedbush PacGrow Healthcare Conference
finance.yahoo.com - August 6 at 8:30 AM
United Therapeutics (UTHR) Q2 Earnings & Sales Beat, Down Y/YUnited Therapeutics (UTHR) Q2 Earnings & Sales Beat, Down Y/Y
finance.yahoo.com - August 2 at 1:11 AM
United Therapeutics Corporation (UTHR) CEO Dr. Martine Rothblatt on Q2 2019 Results - Earnings Call TranscriptUnited Therapeutics Corporation (UTHR) CEO Dr. Martine Rothblatt on Q2 2019 Results - Earnings Call Transcript
seekingalpha.com - August 1 at 12:26 AM
United Therapeutics is executing its growth plan. Why isn’t its stock price higher?United Therapeutics is executing its growth plan. Why isn’t its stock price higher?
finance.yahoo.com - August 1 at 12:26 AM
United Therapeutics Corporation (UTHR) 2019 Q2 Earnings Call TranscriptUnited Therapeutics Corporation (UTHR) 2019 Q2 Earnings Call Transcript
finance.yahoo.com - August 1 at 12:26 AM
United Therapeutics EPS beats by $0.89, beats on revenueUnited Therapeutics EPS beats by $0.89, beats on revenue
seekingalpha.com - July 31 at 8:41 AM
United Therapeutics up 1% premarket on Q2 beatUnited Therapeutics up 1% premarket on Q2 beat
seekingalpha.com - July 31 at 8:41 AM
United Therapeutics (UTHR) Q2 Earnings and Revenues Beat EstimatesUnited Therapeutics (UTHR) Q2 Earnings and Revenues Beat Estimates
finance.yahoo.com - July 31 at 8:41 AM
United Therapeutics Q2 2019 Earnings PreviewUnited Therapeutics Q2 2019 Earnings Preview
seekingalpha.com - July 30 at 11:41 PM
United Therapeutics Corporation To Report Second Quarter 2019 Financial Results Before The Market Opens On Wednesday, July 31, 2019United Therapeutics Corporation To Report Second Quarter 2019 Financial Results Before The Market Opens On Wednesday, July 31, 2019
finance.yahoo.com - July 24 at 6:16 AM
What You Should Know About United Therapeutics Corporation's (NASDAQ:UTHR) Financial StrengthWhat You Should Know About United Therapeutics Corporation's (NASDAQ:UTHR) Financial Strength
finance.yahoo.com - July 17 at 7:03 PM
What To Do With United Therapeutics As Stock Continues FallingWhat To Do With United Therapeutics As Stock Continues Falling
seekingalpha.com - July 11 at 6:42 PM
Sexual harassment lawsuit against Md. biotech to advance with plaintiff's identity revealedSexual harassment lawsuit against Md. biotech to advance with plaintiff's identity revealed
finance.yahoo.com - July 11 at 8:08 AM
United Therapeutics Stock Jumps After Analyst Says Its Slide Was OverdoneUnited Therapeutics Stock Jumps After Analyst Says Its Slide Was Overdone
finance.yahoo.com - July 1 at 7:13 PM
Credit Suisse: United Therapeutics Becoming More Fundamentally DrivenCredit Suisse: United Therapeutics Becoming More Fundamentally Driven
finance.yahoo.com - July 1 at 7:13 PM
Have Insiders Been Selling United Therapeutics Corporation (NASDAQ:UTHR) Shares?Have Insiders Been Selling United Therapeutics Corporation (NASDAQ:UTHR) Shares?
finance.yahoo.com - June 18 at 6:15 AM
Here’s What Hedge Funds Think About United Therapeutics Corporation (UTHR)Here’s What Hedge Funds Think About United Therapeutics Corporation (UTHR)
finance.yahoo.com - June 13 at 7:55 PM
Impact on Jacksonville of mega-merger of United Technologies and Raytheon is uncertainImpact on Jacksonville of mega-merger of United Technologies and Raytheon is uncertain
finance.yahoo.com - June 10 at 7:07 PM
United Therapeutics Corporation (UTHR) Presents At 2019 Jefferies Global Healthcare Conference - SlideshowUnited Therapeutics Corporation (UTHR) Presents At 2019 Jefferies Global Healthcare Conference - Slideshow
seekingalpha.com - June 6 at 7:27 PM
RSI Alert: United Therapeutics (UTHR) Now OversoldRSI Alert: United Therapeutics (UTHR) Now Oversold
www.nasdaq.com - May 31 at 7:06 PM
United Therapeutics Corporation To Present at Jefferies 2019 Healthcare ConferenceUnited Therapeutics Corporation To Present at Jefferies 2019 Healthcare Conference
finance.yahoo.com - May 28 at 8:02 AM
The Catalyst: Creating Innovation in Health Care - United Therapeutics' Martine Rothblatt at Healthy ReturnsThe Catalyst: Creating Innovation in Health Care - United Therapeutics' Martine Rothblatt at Healthy Returns
finance.yahoo.com - May 23 at 7:38 PM
First Week of July 19th Options Trading For United Therapeutics (UTHR)First Week of July 19th Options Trading For United Therapeutics (UTHR)
www.nasdaq.com - May 21 at 7:39 PM
Relative Strength Alert For United TherapeuticsRelative Strength Alert For United Therapeutics
www.nasdaq.com - May 10 at 8:06 AM
Before You Buy United Therapeutics Corporation (NASDAQ:UTHR), Consider Its VolatilityBefore You Buy United Therapeutics Corporation (NASDAQ:UTHR), Consider Its Volatility
finance.yahoo.com - May 8 at 7:49 PM
FDA clears subcutaneous delivery system for Uniteds RemodulinFDA clears subcutaneous delivery system for United's Remodulin
seekingalpha.com - May 7 at 7:14 PM
United Therapeutics And DEKA Announce FDA Clearance Of The Unity Subcutaneous Delivery System For Remodulin®United Therapeutics And DEKA Announce FDA Clearance Of The Unity Subcutaneous Delivery System For Remodulin®
finance.yahoo.com - May 7 at 8:09 AM
MannKind - Quarterly Call On Deck, Afrezza Scripts, CashMannKind - Quarterly Call On Deck, Afrezza Scripts, Cash
seekingalpha.com - May 5 at 5:56 PM
United Therapeutics zeroes in on new business lines in wake of generic competitionUnited Therapeutics zeroes in on new business lines in wake of generic competition
www.bizjournals.com - May 2 at 8:13 PM
Edited Transcript of UTHR earnings conference call or presentation 1-May-19 1:00pm GMTEdited Transcript of UTHR earnings conference call or presentation 1-May-19 1:00pm GMT
finance.yahoo.com - May 2 at 8:07 AM
United Therapeutics Corporation (UTHR) CEO Martine Rothblatt on Q1 2019 Results - Earnings Call TranscriptUnited Therapeutics Corporation (UTHR) CEO Martine Rothblatt on Q1 2019 Results - Earnings Call Transcript
seekingalpha.com - May 1 at 7:40 PM
United Therapeutics Corporation (UTHR) Q1 2019 Earnings Call TranscriptUnited Therapeutics Corporation (UTHR) Q1 2019 Earnings Call Transcript
finance.yahoo.com - May 1 at 7:40 PM
United Therapeutics (UTHR) Beats Q1 Earnings and Revenue EstimatesUnited Therapeutics (UTHR) Beats Q1 Earnings and Revenue Estimates
finance.yahoo.com - May 1 at 7:40 PM
United Therapeutics Corporation Reports First Quarter 2019 Financial ResultsUnited Therapeutics Corporation Reports First Quarter 2019 Financial Results
finance.yahoo.com - May 1 at 8:03 AM
United Therapeutics beats Q1 consensusUnited Therapeutics beats Q1 consensus
seekingalpha.com - May 1 at 8:03 AM
United Therapeutics Q1 2019 Earnings PreviewUnited Therapeutics Q1 2019 Earnings Preview
seekingalpha.com - April 30 at 7:05 PM
FDA approves United Therapeutics XPS and Steen Solution for EVLP servicesFDA approves United Therapeutics' XPS and Steen Solution for EVLP services
seekingalpha.com - April 29 at 8:00 AM
United Therapeutics Announces FDA Approval Of XPS™ And Steen Solution™ Used To Perform Centralized Ex-Vivo Lung Perfusion ServicesUnited Therapeutics Announces FDA Approval Of XPS™ And Steen Solution™ Used To Perform Centralized Ex-Vivo Lung Perfusion Services
finance.yahoo.com - April 29 at 8:00 AM
This page was last updated on 10/14/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel